- UroToday Home
- Recent Abstracts
- Urologic Oncology
Bladder Cancer
Tumor Infiltrating Myeloid Cells Confer de novo Resistance to PD-L1 Blockade through EMT-stromal and Tgf-beta Dependent Mechanisms.
September 23, 2022
Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition Syndromes.
September 23, 2022
Impact of exercise on physical health status in bladder cancer patients.
September 22, 2022
Outcomes of radical cystectomy in pT4 bladder cancer frail patients: Α high-volume single center study.
September 22, 2022
BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patients.
September 21, 2022
Radiomics Signature Using Manual Versus Automated Segmentation for Lymph Node Staging of Bladder Cancer.
September 21, 2022
Inter-reader reliability of the vesical imaging-reporting and data system (VI-RADS) for muscle-invasive bladder cancer: a systematic review and meta-analysis.
September 21, 2022
Ligand-receptor Interactions as a Prognostic Tool in Bladder Cancer - Expert Commentary
September 20, 2022
Neoadjuvant chemotherapy for muscle-invasive bladder cancer: does variant histology matter?
September 19, 2022
Online Crowdfunding for Urologic Cancer Care.
September 19, 2022
Oncologic Validation and Discriminative Ability of Pentafecta Criteria After Open Radical Cystectomy.
September 16, 2022
Extent of lymph node dissection and impact on survival in radical cystectomy for advanced bladder cancer.
September 16, 2022
Adverse events during neoadjuvant chemotherapy for muscle invasive bladder cancer-a Swedish retrospective multicentre study of a clinical database.
September 15, 2022
Prognostic significance of systemic immune-inflammation index in patients with bladder cancer: A systematic review and meta-analysis.
September 14, 2022
